Showing 1791-1800 of 4698 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-44/23875/On the Leading Edge, Not the Bleeding Edge: Joe Niamtu, DMD
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/on-the-leading-edge-not-the-bleeding-edge-joe-niamtu-dmd/18606/Innovator, influencer, and podium perennial Joe Niatmu, III, DMD has built a successful surgical aesthetic practice by focusing on the basics, concentrating on his strengths, and avoiding passing fads. How does he stay passionate, spot the best new developments, and build a fulfilling practice? In tLong-term Management Strategies for AD, Melasma, and More
https://practicaldermatology.com/topics/psoriasis/long-term-management-strategies-for-ad-melasma-and-more/20801/After the acute treatment phase, experts urge a long-view on management.Currents: Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/currents-eczema/23371/Dermatology Q&A: New Directions in the Treatment of Hypopigmented Scars
https://practicaldermatology.com/topics/general-topics/dermatology-qa-new-directions-in-the-treatment-of-hypopigmented-scars/21980/A new study shows that off-label use of an unexpected agent yields promising results in the repigmentation of hypopigmented scars.@PRACTICAL_DERM
https://practicaldermatology.com/topics/skin-cancer-photoprotection/practical_derm/21185/Case Report, Plus Top Resident Presentations from CSF 2014, and Ask an Expert
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-plus-top-resident-presentations-from-csf-2014-and-ask-an-expert/21226/The State of Private Equity in 2024: Impact on the Practice of Dermatology
https://practicaldermatology.com/columns/practice-management/state-private-equity-2024-impact-practice-dermatology/27173/Physician Growth Partners recently published a white paper, “State of Dermatology Private Equity,” that evaluated market trends, strategies, and more. Practical Dermatology® spoke exclusively with CEO Michael Kroin about how the evolution of private equity is impacting the everyday practitioner andCaring for Acne and Rosacea Patients in the COVID-19 Era
https://practicaldermatology.com/topics/acne-rosacea/caring-for-acne-and-rosacea-patients-in-the-covid-19-era/23280/Telederm may not be ideal, but it is essential for acne and rosacea patients today—and could persist in the future.Acne Management Today: Exploring the Role of Topical Adapalene in OTC Care
https://practicaldermatology.com/topics/acne-rosacea/acne-management-today-exploring-the-role-of-topical-adapalene-in-otc-care/23205/La Roche-Posay’s EFFACLAR Adapalene 0.1% Gel provides effective OTC care for acne.